Inherited hearing loss: molecular genetics and diagnostic testing

Bibliography

• Petit C, Levilliers J, Marlin S, Hardelin J-P. Hereditary hearing loss. In: The Metabolic & Molecular Bases of Inherited Disease. 8th edition. Volume IV. Scriver CR, Beaudet AL, Sly WS, Valle D, editors. McGraw Hill, NY, USA; 2001. p. 6281-328
   Google Scholar
• Tekin M, Arnos KS, Pandya A. Advances in hereditary deafness. Lancet 2001;358(9287):1082-90
   PubMed Web of Science ®Google Scholar
• Keats BJ, Berlin CI. Genomics and hearing impairment. Genome Res 1999;9(1):7-16
   PubMed Web of Science ®Google Scholar
• Van Camp G, Smith RJH. Hereditary Hearing Loss Homepage. Available from: URL: webhost.ua.ac.be/hhh/ [last accessed February 2008]
   Google Scholar
• Kochhar A, Hildebrand MS, Smith RJ. Clinical aspects of hereditary hearing loss. Genet Med 2007;9(7):393-408
   PubMed Web of Science ®Google Scholar
• Cohen MM, Gorlin RJ. Epidemiology, etiology and genetic patterns. In: Hereditary Hearing Loss and its Syndromes. No 28. Gorlin RJ, Toriello HV, Cohen MM, editors. Oxford Monographs on Medical Genetics, Oxford University Press, New York; 1995. p. 9-21
   Google Scholar
• Smith RJ, Hone S. Genetic screening for deafness. Pediatr Clin North Am 2003;50(2):315-29
   PubMed Web of Science ®Google Scholar
• Rose SP, Conneally PM, Nance WE. Genetic analysis of childhood deafness. In: Childhood Deafness. Bess FH, editor. Grune and Stratton, New York; 1977. p. 9-35
   Google Scholar
• Nance WE. The genetics of deafness. Ment Retard Dev Disabil Res Rev 2003;9(2):109-19
   PubMedGoogle Scholar
• Morton CC. Genetics, genomics and gene discovery in the auditory system. Hum Mol Genet 2002;11(10):1229-40
   PubMed Web of Science ®Google Scholar
• Wangemann P. Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential. J Physiol 2006;576(Pt 1):11-21
   PubMed Web of Science ®Google Scholar
• Eisen MD, Ryugo DK. Hearing molecules: contributions from genetic deafness. Cell Mol Life Sci 2007;64(5):566-80
   PubMed Web of Science ®Google Scholar
• Cho A. Physiology. Math clears up an inner-ear mystery: spiral shape pumps up the bass. Science 2006;311(5764):1087
   PubMed Web of Science ®Google Scholar
• Manoussaki D, Dimitriadis EK, Chadwick RS. Cochlea's graded curvature effect on low frequency waves. Phys Rev Lett 2006;96(8):088701
   Web of Science ®Google Scholar
• Parsons TD. Neurobiology: auditory fidelity. Nature 2006;444(7122):1013-4
   PubMed Web of Science ®Google Scholar
• Dallos P, Zheng J, Cheatham MA. Prestin and the cochlear amplifier. J Physiol 2006;576(Pt 1):37-42
   PubMed Web of Science ®Google Scholar
• Cryns K, Van Camp G. Deafness genes and their diagnostic applications. Audiol Neurootol 2004;9(1):2-22
   PubMed Web of Science ®Google Scholar
• Kros CJ. Physiology of mammalian hair cells. In: Springer Handbook of Auditory Research: the Cochlea. Dallos P, Popper AN, Fay R, editors. New York: Springer; 1996 p. 319-85
   Google Scholar
• Spicer SS, Schulte BA. The fine structure of spiral ligament cells relates to ion return to the stria and varies with place-frequency. Hear Res 1996;100(1-2):80-100
   PubMed Web of Science ®Google Scholar
• Marcus DC, Wu T, Wangemann P, Kofuji P. KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol 2002;282(2):C403-7
   PubMed Web of Science ®Google Scholar
• Sunose H, Liu J, Marcus DC. cAMP increases K+ secretion via activation of apical IsK/KvLQT1 channels in strial marginal cells. Hear Res 1997;114(1-2):107-16
   PubMed Web of Science ®Google Scholar
• Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Ann Rev Biochem 1996;65:475-502
   PubMed Web of Science ®Google Scholar
• Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996;84(3):381-8
   PubMed Web of Science ®Google Scholar
• Makowski L, Caspar DLD, Phillips WC, Goodenough DA. Gap junction structures. II. Analysis of the x-ray diffraction data. J Cell Biol 1977;74(2):629-45
   PubMed Web of Science ®Google Scholar
• Brink PR, Cronin K, Banach K, et al. Evidence for heteromeric gap junction channels formed from rat connexin43 and human connexin37. Am J Physiol 1997;273(4 Pt 1):C1386-96
   PubMed Web of Science ®Google Scholar
• Evans WH, Martin PE. Gap junctions: structure and function (Review). Mol Membr Biol 2002;19(2):121-36
   PubMed Web of Science ®Google Scholar
• Rabionet R, Lopez-Bigas N, Arbones ML, Estivill X. Connexin mutations in hearing loss, dermatological and neurological disorders. Trends Mol Med 2002;8(5):205-12
   PubMed Web of Science ®Google Scholar
• Willecke K, Eiberger J, Degen J, et al. Structural and functional diversity of connexin genes in mouse and human genome. Biol Chem 2002;383(5):725-37
   PubMed Web of Science ®Google Scholar
• Sohl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes 2003;10(4-6):173-80
   PubMed Web of Science ®Google Scholar
• Richard G. Connexin gene pathology. Clin Exp Dermatol 2003;28(4):397-409
   PubMed Web of Science ®Google Scholar
• Zhao HB. Connexin26 is responsible for anionic molecule permeability in the cochlea for intercellular signalling and metabolic communications. Eur J Neurosci 2005;21(7):1859-68
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Kimura RS, Paul DL, et al. Gap junction systems in the mammalian cochlea. Brain Res Brain Res Rev 2000;32(1):163-6
   PubMed Web of Science ®Google Scholar
• OMIM - Online Mendelian Inheritance in Man. Available from: URL: www.ncbi.nlm.nih.gov/sites/entrez?db=omim [last accessed February 2008]
   Google Scholar
• Van Laer L, Cryns K, Smith RJH, Van Camp G. Nonsyndromic Hearing Loss. Ear Hearing 2003;24:275-88
   PubMed Web of Science ®Google Scholar
• GeneTests. Available from: URL: www.genetests.org [last accessed February 2008]
   Google Scholar
• Petit C. From deafness genes to hearing mechanisms: harmony and counterpoint. Trends Mol Med 2006;12(2):57-64
   PubMed Web of Science ®Google Scholar
• Kelley PM, Abe S, Askew JW, et al. Human connexin 30 (GJB6), a candidate gene for nonsyndromic hearing loss: molecular cloning, tissue-specific expression, and assignment to chromosome 13q12. Genomics 1999;62(2):172-6
   PubMed Web of Science ®Google Scholar
• Del Castillo I, Moreno-Pelayo MA, Del Castillo FJ, et al. Prevalence and evolutionary origins of the del(GJB6-D13S1830) mutation in the DFNB1 locus in hearing-impaired subjects: a multicenter study. Am J Hum Genet 2003;73(6):1452-8
   PubMed Web of Science ®Google Scholar
• Denoyelle F, Weil D, Maw MA, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 1997;6(12):2173-7
   PubMed Web of Science ®Google Scholar
• Morell RJ, Kim HJ, Hood LJ, et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med 1998;339(21):1500-5
   PubMed Web of Science ®Google Scholar
• Kudo T, Ikeda K, Kure S, et al. Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafnes in the Japanese population. Am J Med Genet 2000;90(2):141-5
   PubMed Web of Science ®Google Scholar
• Matos TD, Caria H, Simoes-Teixeira H, et al. A novel hearing loss related mutation occurring in the GJB2 basal promoter. J Med Genet 2007;44(11):721-5
   PubMed Web of Science ®Google Scholar
• Del Castillo FJ, Rodriguez-Ballesteros M, Alvarez A, et al. A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J Med Genet 2005;42(7):588-94
   PubMed Web of Science ®Google Scholar
• Schrijver I, Gardner P. Hereditary sensorineural hearing loss: advances in molecular genetics and mutation analysis. Expert Rev Mol Diagn 2006;6(3):375-86
   PubMed Web of Science ®Google Scholar
• Wilch E, Zhu M, Burkhart KB, et al. Expression of GJB2 and GJB6 Is Reduced in a Novel DFNB1 Allele. Am J Hum Genet 2006;79(1):174-9
   PubMed Web of Science ®Google Scholar
• The Connexin-deafness homepage. Available from: URL: davinci.crg.es/deafness [last accessed February 2008]
   Google Scholar
• Prasad S, Kolln KA, Cucci RA, et al. Pendred syndrome and DFNB4-mutation screening of SLC26A4 by denaturing high-performance liquid chromatography and the identification of eleven novel mutations. Am J Med Genet A 2004;124(1):1-9
   Google Scholar
• Scott DA, Wang R, Kreman TM, et al. Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet 2000;9(11):1709-15
   PubMed Web of Science ®Google Scholar
• Azaiez H, Yang T, Prasad S, et al. Genotype-phenotype correlations for SLC26A4-related deafness. Hum Genet 2007;122(5):451-7
   PubMed Web of Science ®Google Scholar
• Varga R, Avenarius MR, Kelley PM, et al. OTOF mutations revealed by genetic analysis of hearing loss families including a potential temperature sensitive auditory neuropathy allele. J Med Genet 2006;43(7):576-81
   PubMed Web of Science ®Google Scholar
• Yasunaga S, Grati M, Cohen-Salmon M, et al. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 1999;21(4):363-9
   PubMed Web of Science ®Google Scholar
• Yasunaga S, Petit C. Physical map of the region surrounding the OTOFERLIN locus on chromosome 2p22-p23. Genomics 2000;66(1):110-2
   PubMed Web of Science ®Google Scholar
• Houseman MJ, Jackson AP, Al-Gazali LI, et al. A novel mutation in a family with non-syndromic sensorineural hearing loss that disrupts the newly characterised OTOF long isoforms. J Med Genet 2001;38(8):E25
   PubMed Web of Science ®Google Scholar
• Mirghomizadeh F, Pfister M, Apaydin F, et al. Substitutions in the conserved C2C domain of otoferlin cause DFNB9, a form of nonsyndromic autosomal recessive deafness. Neurobiol Dis 2002;10(2):157-64
   PubMed Web of Science ®Google Scholar
• Varga R, Kelley PM, Keats BJ, et al. Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene. J Med Genet 2003;40(1):45-50
   PubMed Web of Science ®Google Scholar
• Roux I, Safieddine S, Nouvian R. Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 2006;127(2):277-89
   PubMed Web of Science ®Google Scholar
• Migliosi V, Modamio-Hoybjor S, Moreno-Pelayo MA, et al. Q829X, a novel mutation in the gene encoding otoferlin (OTOF), is frequently found in Spanish patients with prelingual non-syndromic hearing loss. J Med Genet 2002;39(7):502-6
   PubMed Web of Science ®Google Scholar
• Yasunaga S, Grati M, Chardenoux S, et al. OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9. Am J Hum Genet 2000;67(3):591-600
   PubMed Web of Science ®Google Scholar
• Schug N, Braig C, Zimmermann U, et al. Differential expression of otoferlin in brain, vestibular system, immature and mature cochlea of the rat. Eur J Neurosci 2006;24(12):3372-80
   PubMed Web of Science ®Google Scholar
• Zheng J, Du GG, Anderson CT, et al. Analysis of the oligomeric structure of the motor protein prestin. J Biol Chem 2006;281(29):19916-24
   PubMed Web of Science ®Google Scholar
• Zheng J, Du GG, Matsuda K, et al. The C-terminus of prestin influences nonlinear capacitance and plasma membrane targeting. J Cell Sci 2005;118(Pt 13):2987-96
   PubMed Web of Science ®Google Scholar
• Liu XZ, Ouyang XM, Xia XJ, et al. Prestin, a cochlear motor protein, is defective in non-syndromic hearing loss. Hum Mol Genet 2003;12(10):1155-62
   PubMed Web of Science ®Google Scholar
• Tang HY, Xia A, Oghalai JS, et al. High frequency of the IVS2-2A>G DNA sequence variation in SLC26A5, encoding the cochlear motor protein prestin, precludes its involvement in hereditary hearing loss. BMC Med Genet 2005;6:30
   PubMed Web of Science ®Google Scholar
• Grifa A, Wagner CA, D'Ambrosio L, et al. Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 1999;23(1):16-8
   PubMed Web of Science ®Google Scholar
• Cryns K, Thys S, Van Laer L. The WFS1gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells. Histochem Cell Biol 2003;119(3):247-56
   PubMed Web of Science ®Google Scholar
• Takeda K, Inoue H, Tanizawa Y, et al. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 2001;10(5):477-84
   PubMed Web of Science ®Google Scholar
• Bespalova IN, Van Camp G, Bom SJ, et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet 2001;10(22):2501-8
   PubMed Web of Science ®Google Scholar
• Inoue H, Tanizawa Y, Wasson J, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 1998;20(2):143-8
   PubMed Web of Science ®Google Scholar
• Strom TM, Hortnagel K, Hofmann S, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 1998;7(13):2021-8
   PubMed Web of Science ®Google Scholar
• Robertson NG, Cremers CW, Huygen PL, et al. Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction. Hum Mol Genet 2006;15(7):1071-85
   PubMed Web of Science ®Google Scholar
• Robertson NG, Hamaker SA, Patriub V, et al. Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9. J Med Genet 2003;40(7):479-86
   PubMed Web of Science ®Google Scholar
• Grabski R, Szul T, Sasaki T, et al. Mutations in COCH that result in non-syndromic autosomal dominant deafness (DFNA9) affect matrix deposition of cochlin. Hum Genet 2003;113(5):406-16
   PubMed Web of Science ®Google Scholar
• Lemaire FX, Feenstra L, Huygen PL, et al. Progressive late-onset sensorineural hearing loss and vestibular impairment with vertigo (DFNA9/COCH): longitudinal analyses in a Belgian family. Otol Neurotol 2003;24(5):743-8
   PubMed Web of Science ®Google Scholar
• Ikezono T, Shindo S, Li L, et al. Identification of a novel Cochlin isoform in the perilymph: insights to Cochlin function and the pathogenesis of DFNA9. Biochem Biophys Res Commun 2004;314(2):440-6
   PubMed Web of Science ®Google Scholar
• Fransen E, Verstreken M, Verhagen WI, et al. High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999;8(8):1425-9
   PubMed Web of Science ®Google Scholar
• Kharkovets T, Hardelin JP, Safieddine S, et al. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc Natl Acad Sci USA 2000;97(8):4333-8
   PubMed Web of Science ®Google Scholar
• Robbins J. KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther 2001;90(1):1-19
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang D, Gingell RL, et al. Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation 1999;99(10):1344-7
   PubMed Web of Science ®Google Scholar
• Coucke PJ, Van Hauwe P, Kelley PM. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet 1999;8(7):1321-8
   PubMed Web of Science ®Google Scholar
• Demolombe S, Baro I, Pereon Y, et al. A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem 1998;273(12):6837-43
   PubMed Web of Science ®Google Scholar
• Van Camp G, Coucke PJ, Kunst H, et al. Linkage analysis of progressive hearing loss in five extended families maps the DFNA2 gene to a 1.25-Mb region on chromosome 1p. Genomics 1997;41(1):70-4
   PubMed Web of Science ®Google Scholar
• Cremers CW. How to prevent a stapes gusher. Adv Otorhinolaryngol 2007;65:278-84
   PubMedGoogle Scholar
• Vore AP, Chang EH, Hoppe JE, et al. Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness. Arch Otolaryngol Head Neck Surg 2005;131(12):1057-63
   PubMed Web of Science ®Google Scholar
• De Kok YJ, Cremers CW, Ropers HH, Cremers FM. The molecular basis of X-linked deafness type 3 (DFN3) in two sporadic cases: identification of a somatic mosaicism for a POU3F4 missense mutation. Hum Mutat 1997;10(3):207-11
   PubMed Web of Science ®Google Scholar
• Oh N, Kupka S, Mirghomizadeh F, et al. Clinical and molecular genetic analysis of monozygotic twins displaying stapes gusher syndrome (DFN3). HNO 2003;51(8):629-33
   PubMed Web of Science ®Google Scholar
• Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005;6(5):389-402
   PubMed Web of Science ®Google Scholar
• Wallace D, Ye JH, Neckelmann SN, et al. Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet 1987;12(2):81-90
   PubMed Web of Science ®Google Scholar
• Kokotas H, Petersen MB, Willems PJ. Mitochondrial deafness. Clin Genet 2007;71(5):379-91
   PubMed Web of Science ®Google Scholar
• Chinnery PF, Turnbull DM. Mitochondrial DNA mutations in the pathogenesis of human disease. Mol Med Today 2000;6(11):425-32
   PubMedGoogle Scholar
• Korres S, Balatsouras D, Manta P, et al. Cochlear dysfunction in patients with mitochondrial myopathy. ORL J Otorhinolaryngol Relat Spec 2002;64(5):315-20
   PubMed Web of Science ®Google Scholar
• Mitomap: a human mitochondrial genome database. Available from: URL: www.mitomap.org [last accessed February 2008]
   Google Scholar
• Del Castillo FJ, Rodriguez-Ballesteros M, Martin Y, et al. Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss. J Med Genet 2003;40(8):632-6
   PubMed Web of Science ®Google Scholar
• Bravo O, Ballana E, Estivill X. Cochlear alterations in deaf and unaffected subjects carrying the deafness-associated A1555G mutation in the mitochondrial 12S rRNA gene. Biochem Biophys Res Commun 2006;344(2):511-6
   PubMed Web of Science ®Google Scholar
• Hamasaki K, Rando RR. Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness. Biochemistry 1997;36(40):12323-8
   PubMed Web of Science ®Google Scholar
• Ballana E, Morales E, Rabionet R. Mitochondrial 12S rRNA gene mutations affect RNA secondary structure and lead to variable penetrance in hearing impairment. Biochem Biophys Res Commun 2006;341(4):950-7
   PubMed Web of Science ®Google Scholar
• Guan MX. Molecular pathogenetic mechanism of maternally inherited deafness. Ann NY Acad Sci 2004;1011:259-71
   PubMed Web of Science ®Google Scholar
• Green GE, Scott DA, Mcdonald JM, et al. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA 1999;281(23):2211-6
   PubMed Web of Science ®Google Scholar
• Putcha GV, Bejjani BA, Bleoo S, et al. A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort. Genet Med 2007;9(7):413-26
   PubMed Web of Science ®Google Scholar
• Ellis LA, Taylor CF, Taylor GR. A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutations screening. Hum Mutat 2000;15(6):556-64
   PubMed Web of Science ®Google Scholar
• Forli F, Passetti S, Mancuso M, et al. Mitochondrial syndromic sensorineural hearing loss. Biosci Rep 2007;27(1-3):113-23
   PubMed Web of Science ®Google Scholar
• Li R, Greinwald JH, Yang L, et al. Molecular analysis of the mitochondrial 12S rRNA and tRNASer (UCN) genes in paediatric subjects with non-syndromic hearing loss. J Med Genet 2004;41(8):615-20
   PubMed Web of Science ®Google Scholar
• Kupka S, Braun S, Aberle S, et al. Frequencies of GJB2 mutations in German control individuals and patients showing sporadic non-syndromic hearing impairment. Hum Mutat 2002;20(1):77-8
   PubMedGoogle Scholar
• Usami S, Abe S, Akita J, et al. Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet 2000;37(1):38-40
   PubMed Web of Science ®Google Scholar
• Gardner P, Oitmaa E, Messner A, et al. Simultaneous multigene mutation detection in patients with sensorineural hearing loss through a novel diagnostic microarray: a new approach for newborn screening follow-up. Pediatrics 2006;118(3):985-94
   PubMed Web of Science ®Google Scholar
• Kalatzis V, Sahly I, El-Amraoui A, Petit C. Eya1 expression in the developing ear and kidney: towards the understanding of the pathogenesis of Branchio-Oto-Renal (BOR) syndrome. Dev Dyn 1998;213(4):486-99
   PubMed Web of Science ®Google Scholar
• Friedman TB, Schultz JM, Ben-Yosef T, et al. Recent advances in the understanding of syndromic forms of hearing loss. Ear Hear 2003;24(4):289-302
   PubMed Web of Science ®Google Scholar
• Kibar Z, Dube MP, Powell J, et al. Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder effect in the French Canadian population and fine genetic mapping. Eur J Hum Genet 2000;8(5):372-80
   PubMed Web of Science ®Google Scholar
• Nayak CS, Isaacson G. Worldwide distribution of Waardenburg syndrome. Ann Otol Rhinol Laryngol 2003;112(9 Pt 1):817-20
   PubMed Web of Science ®Google Scholar
• Dourmishev AL, Dourmishev LA, Schwartz RA, Janniger CK. Waardenburg syndrome. Int J Dermatol 1999;38(9):656-63
   PubMed Web of Science ®Google Scholar
• Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet 1951;3(3):195-253
   PubMed Web of Science ®Google Scholar
• Hoth CF, Milunsky A, Lipsky N, et al. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet 1993;52(3):455-62
   PubMed Web of Science ®Google Scholar
• Destefano AL, Cupples LA, Arnos KS, et al. Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations. Hum Genet 1998;102(5):499-506
   PubMed Web of Science ®Google Scholar
• Read AP, Newton VE. Waardenburg syndrome. J Med Genet 1997;34(8):656-65
   PubMed Web of Science ®Google Scholar
• Nobukuni Y, Watanabe A, Takeda K, et al. Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A. Am J Hum Genet 1996;59(1):76-83
   PubMed Web of Science ®Google Scholar
• Sanchez-Martin M, Rodriguez-Garcia A, Perez-Losada J, et al. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 2002;11(25):3231-6
   PubMed Web of Science ®Google Scholar
• Edery P, Attie T, Amiel J, et al. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 1996;12(4):442-4
   PubMed Web of Science ®Google Scholar
• Milunsky JM, Maher TA, Ito M, Milunsky A. The value of MLPA in Waardenburg syndrome. Genet Test 2007;11(2):179-82
   PubMedGoogle Scholar
• Madden C, Halsted MJ, Hopkin RJ, et al. Temporal bone abnormalities associated with hearing loss in Waardenburg syndrome. Laryngoscope 2003;113(11):2035-41
   PubMed Web of Science ®Google Scholar
• Ahmad NN, Ala-Kokko L, Knowlton RG, et al. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci USA 1991;88(15):6624-7
   PubMed Web of Science ®Google Scholar
• Niffenegger JH, Topping TM, Mukai S. Stickler's syndrome. Int Ophthalmol Clin 1993;33(2):271-80
   PubMedGoogle Scholar
• Snead MP, Yates JR. Clinical and molecular genetics of Stickler syndrome. J Med Genet 1999;36(5):353-9
   PubMed Web of Science ®Google Scholar
• Fraser FC, Sproule JR, Halal F. Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet 1980;7(3):341-9
   PubMed Web of Science ®Google Scholar
• Melnick M, Bixler D, Silk K, et al. Autosomal dominant branchiootorenal dysplasia. Birth Defects Orig Artic Ser 1975;11(5):121-8
   PubMedGoogle Scholar
• Stratakis CA, Lin JP, Rennert OM. Description of a large kindred with autosomal dominant inheritance of branchial arch anomalies, hearing loss, and ear pits, and exclusion of the branchio-oto-renal (BOR) syndrome gene locus (chromosome 8q13.3). Am J Med Genet 1998;79(3):209-14
   PubMed Web of Science ®Google Scholar
• Chen A, Francis M, Ni L, et al. Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 1995;58(4):365-70
   PubMed Web of Science ®Google Scholar
• Kochhar A, Fischer SM, Kimberling WJ, Smith RJ. Branchio-oto-renal syndrome. Am J Med Genet A 2007;143(14):1671-8
   Google Scholar
• Hoskins BE, Cramer CH, Silvius D, et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007;80(4):800-4
   PubMed Web of Science ®Google Scholar
• Chang EH, Menezes M, Meyer NC, et al. Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat 2004;23(6):582-9
   PubMed Web of Science ®Google Scholar
• Sanggaard KM, Rendtorff ND, Kjaer KW, et al. Branchio-oto-renal syndrome: detection of EYA1 and SIX1 mutations in five out of six Danish families by combining linkage, MLPA and sequencing analyses. Eur J Hum Genet 2007;15(11):1121-31
   PubMed Web of Science ®Google Scholar
• The Pendred/BOR webpage. Available from: URL: www.medicine.uiowa.edu/pendredandbor [last accessed February 2008]
   Google Scholar
• Evans DG, Moran A, King A, et al. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 2005;26(1):93-7
   PubMed Web of Science ®Google Scholar
• Yohay K. Neurofibromatosis types 1 and 2. Neurologist 2006;12(2):86-93
   PubMed Web of Science ®Google Scholar
• Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992;84(304):603-18
   PubMedGoogle Scholar
• Parry DM, Maccollin MM, Kaiser-Kupfer MI, et al. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 1996;59(3):529-39
   PubMed Web of Science ®Google Scholar
• Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002;3(8):586-99
   PubMed Web of Science ®Google Scholar
• Kluwe L, Nygren AO, Errami A, et al. Screening for large mutations of the NF2 gene. Genes Chromosomes Cancer 2005;42(4):384-91
   PubMed Web of Science ®Google Scholar
• Wallace AJ, Watson CJ, Oward E, et al. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis. Genet Test 2004;8(4):368-80
   PubMedGoogle Scholar
• Tsilchorozidou T, Menko FH, Lalloo F, et al. Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2. J Med Genet 2004;41(7):529-34
   PubMed Web of Science ®Google Scholar
• Richard G, Brown N, Ishida-Yamamoto A, Krol A. Expanding the phenotypic spectrum of Cx26 disorders: Bart-Pumphrey syndrome is caused by a novel missense mutation in GJB2. J Invest Dermatol 2004;123(5):856-63
   PubMed Web of Science ®Google Scholar
• Reardon W, Omahoney CF, Trembath R, et al. Enlarged vestibular aqueduct: a radiological marker of pendred syndrome, and mutation of the PDS gene. QJM 2000;93(2):99-104
   PubMed Web of Science ®Google Scholar
• Dawson PA, Markovich D. Pathogenetics of the human SLC26 transporters. Curr Med Chem 2005;12(4):385-96
   PubMed Web of Science ®Google Scholar
• Kremer H, Van Wijk E, Marker T, et al. Usher syndrome: molecular links of pathogenesis, proteins and pathways. Hum Mol Genet 2006;15(Spec No 2):R262-70
   PubMed Web of Science ®Google Scholar
• Boughman JA, Vernon M, Shaver KA. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis 1983;36(8):595-603
   PubMedGoogle Scholar
• Smith RJ, Berlin CI, Hejtmancik JF, et al. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet 1994;50(1):32-8
   PubMed Web of Science ®Google Scholar
• Kimberling WJ, Moller CG, Davenport SL, et al. Usher syndrome: clinical findings and gene localization studies. Laryngoscope 1989;99(1):66-72
   PubMed Web of Science ®Google Scholar
• Sankila EM, Pakarinen L, Kaariainen H, et al. Assignment of an Usher syndrome type III (USH3) gene to chromosome 3q. Hum Mol Genet 1995;4(1):93-8
   PubMed Web of Science ®Google Scholar
• Ebermann I, Scholl HP, Charbel Issa P, et al. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. Hum Genet 2007;121(2):203-11
   PubMed Web of Science ®Google Scholar
• Ahmed ZM, Smith TN, Riazuddin S, et al. Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC. Hum Genet 2002;110(6):527-31
   PubMed Web of Science ®Google Scholar
• Bitner-Glindzicz M, Lindley KJ, Rutland P, et al. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet 2000;26(1):56-60
   PubMed Web of Science ®Google Scholar
• Lentz J, Savas S, Ng SS, et al. The USH1C 216G-->A splice-site mutation results in a 35-base-pair deletion. Hum Genet 2005;116(3):225-7
   PubMed Web of Science ®Google Scholar
• Maubaret C, Griffoin JM, Arnaud B, Hamel C. Novel mutations in MYO7A and USH2A in Usher syndrome. Ophthalmic Genet 2005;26(1):25-9
   PubMedGoogle Scholar
• Van Wijk E, Pennings RJ, Te Brinke H, et al. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. Am J Hum Genet 2004;74(4):738-44
   PubMed Web of Science ®Google Scholar
• Cremers FP, Kimberling WJ, Kulm M, et al. Development of a genotyping microarray for Usher syndrome. J Med Genet 2007;44(2):153-60
   PubMed Web of Science ®Google Scholar
• Jervell A, Lange-Nielsen F. Congenital deaf mutism, functional heart disease with prolongation of the QT interval and sudden death. Am Heart J 1957;54(1):59-68
   PubMed Web of Science ®Google Scholar
• Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004;292(11):1341-4
   PubMed Web of Science ®Google Scholar
• Priori SG, Napolitano C, Schwartz P. Genetics of cardiac arrhythmia. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Volume I. 7th edition. Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Elsevier Saunders, Philadephia; 2005. p. 690
   Google Scholar
• Tristani-Firouzi M, Chen J, Mitcheson JS, Sanguinetti MC. Molecular biology of K(+) channels and their role in cardiac arrhythmias. Am J Med 2001;110(1):50-9
   PubMed Web of Science ®Google Scholar
• Wollnik B, Schroeder BC, Kubisch C, et al. Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet 1997;6(11):1943-9
   PubMed Web of Science ®Google Scholar
• Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000;102(10):1178-85
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Spazzolini C, Crotti L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006;113(6):783-90
   PubMed Web of Science ®Google Scholar
• Tranebjaerg L, Bathen J, Tyson J, Bitner-Glindzicz M. Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Am J Med Genet 1999;89(3):137-46
   PubMed Web of Science ®Google Scholar
• Tranebjaerg L. Jervell and Lange-Nielsen syndrome. In: Genetic Hearing Loss. Willems PJ, editor. Marcel Dekker Publications, NY; 2004. p. 117-34
   Google Scholar
• Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 2000;11(4):649-57
   PubMed Web of Science ®Google Scholar
• Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: A ‘European Community Alport Syndrome Concerted Action’ study. J Am Soc Nephrol 2003;14(10):2603-10
   PubMed Web of Science ®Google Scholar
• Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 1998;9(9):1736-50
   PubMed Web of Science ®Google Scholar
• Hudson BG. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol 2004;15(10):2514-27
   PubMed Web of Science ®Google Scholar
• Merchant SN, Burgess BJ, Adams JC, et al. Temporal bone histopathology in Alport syndrome. Laryngoscope 2004;114(9):1609-18
   PubMed Web of Science ®Google Scholar
• Martin P, Heiskari N, Zhou J, et al. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol 1998;9(12):2291-301
   PubMed Web of Science ®Google Scholar
• King K, Flinter FA, Green PM. A two-tier approach to mutation detection in the COL4A5 gene for Alport syndrome. Hum Mutat 2006;27(10):1061
   PubMedGoogle Scholar
• Tranebjaerg L, Schwartz C, Eriksen H, et al. A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. J Med Genet 1995;32(4):257-63
   PubMed Web of Science ®Google Scholar
• Tranebjaerg L, Jensen PK, Van Ghelue M, et al. Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8A gene. Ophthalmic Genet 2001;22(4):207-23
   PubMedGoogle Scholar
• Jin H, May M, Tranebjaerg L, et al. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet 1996;14(2):177-80
   PubMed Web of Science ®Google Scholar
• Bahmad F Jr, Merchant SN, Nadol JB Jr, Tranebjaerg L. Otopathology in Mohr-Tranebjaerg syndrome. Laryngoscope 2007;117(7):1202-8
   PubMed Web of Science ®Google Scholar
• Aguirre LA, Del Castillo I, Macaya A, et al. A novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexes, in a Spanish familial case of deafness-dystonia (Mohr-Tranebjaerg) syndrome. Am J Med Genet A 2006;140(4):392-7
   PubMedGoogle Scholar
• Marazita ML, Ploughman LM, Rawlings B, et al. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet 1993;46(5):486-91
   PubMed Web of Science ®Google Scholar
• Karkos PD, Waldron M, Johnson IJ. The MELAS syndrome. Review of the literature: the role of the otologist. Clin Otolaryngol Allied Sci 2004;29(1):1-4
   PubMed Web of Science ®Google Scholar
• Tsutsumi T, Nishida H, Noguchi Y, et al. Audiological findings in patients with myoclonic epilepsy associated with ragged-red fibres. J Laryngol Otol 2001;115(10):777-81
   PubMed Web of Science ®Google Scholar
• Guillausseau PJ, Massin P, Dubois-Laforgue D, et al. Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 2001;134(9 Pt 1):721-8
   PubMed Web of Science ®Google Scholar
• Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1992;1(1):11-5
   PubMed Web of Science ®Google Scholar
• Martin Negrier ML, Coquet M, Moretto BT, et al. Partial triplication of mtDNA in maternally transmitted diabetes mellitus and deafness. Am J Hum Genet 1998;63(4):1227-32
   PubMed Web of Science ®Google Scholar